Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

111
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

100
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Proteinuria and Renal Dysfunction after Intravitreal Injection of Bevacizumab in Patients with Diabetic Nephropathy: A Prospective Observational Study

Pages

  0-0

Abstract

 Background: Proliferative Diabetic Retinopathy (PDR) is one of the most important microvascular complications among the patients with diabetes. Intravitreal anti-vascular endothelial growth factor (Anti-VEGF) agent enacts a key role in PDR. Some studies have dealt with the systemic exposure to these agents after intravitreal administration. However, Renal Dysfunction following this therapy has scarcely been reported. Hence, this study aimed to determine the effect of intravitreal Bevacizumab treatment on the deterioration of renal function and Proteinuria. Materials and Methods: This present prospective observational study was performed on 40 patients with Diabetic Nephropathy and PDR and/or significant diabetic macular edema as the candidates for receiving intravitreal injection of Bevacizumab. To evaluate renal function, changes in the urinary albumin-to-creatinine ratio (UACR), serum creatinine (SCr), and estimated glomerular filtration rate (eGFR) one month after injection were measured. Also, changes in systolic and diastolic blood pressures (BPs), plasma VEGF level, platelet, white blood cell (WBC) counts, and hemoglobin (Hb) level were measured at the baseline and one month after treatment. Results: The mean age of the patients was 60. 3 ± 9. 2 years, and 33 patients were female. The decrease in the plasma VEGF level and platelet count, as well as the increase in diastolic BP, and Hb level were significant. However, systolic BP and WBC count remained unchanged. There were no significant changes in UACR, SCr, and eGFR after the injection as compared to baseline (P>0. 05). Conclusion: Our study indicated that intravitreal Bevacizumab injection was not associated with Renal Dysfunction and Proteinuria in patients with Diabetic Nephropathy. Nevertheless, diastolic BP and Hb level could increase after one month.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    Bagheri, Sina, DORMANESH, BANAFSHE, AFARID, MEHRDAD, & SAGHEB, MOHAMMAD MAHDI. (2018). Proteinuria and Renal Dysfunction after Intravitreal Injection of Bevacizumab in Patients with Diabetic Nephropathy: A Prospective Observational Study. GALEN MEDICAL JOURNAL, 7(1), 0-0. SID. https://sid.ir/paper/786076/en

    Vancouver: Copy

    Bagheri Sina, DORMANESH BANAFSHE, AFARID MEHRDAD, SAGHEB MOHAMMAD MAHDI. Proteinuria and Renal Dysfunction after Intravitreal Injection of Bevacizumab in Patients with Diabetic Nephropathy: A Prospective Observational Study. GALEN MEDICAL JOURNAL[Internet]. 2018;7(1):0-0. Available from: https://sid.ir/paper/786076/en

    IEEE: Copy

    Sina Bagheri, BANAFSHE DORMANESH, MEHRDAD AFARID, and MOHAMMAD MAHDI SAGHEB, “Proteinuria and Renal Dysfunction after Intravitreal Injection of Bevacizumab in Patients with Diabetic Nephropathy: A Prospective Observational Study,” GALEN MEDICAL JOURNAL, vol. 7, no. 1, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/786076/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top